Endovascular Revascularisation versus Open Surgery with Prosthetic Bypass for Femoro-Popliteal Lesions in Patients with Peripheral Arterial Disease

被引:4
|
作者
Zenunaj, Gladiol [1 ]
Acciarri, Pierfilippo [1 ]
Baldazzi, Giulia [2 ]
Cosacco, Alessio Mario [2 ]
Gasbarro, Vincenzo [1 ,2 ]
Traina, Luca [1 ]
机构
[1] Univ Hosp Ferrara, Unit Vasc & Endovasc Surg, I-44124 Ferrara, Italy
[2] Univ Ferrara, Sch Vasc Surg, Dept Translat Med Romagna, I-44121 Ferrara, Italy
关键词
endovascular procedures; femoral popliteal bypass; peripheral arterial disease; prosthetic graft; SUPERFICIAL FEMORAL-ARTERY; DRUG-COATED BALLOON; NITINOL STENTS; ANGIOPLASTY; ISCHEMIA; OUTCOMES; VEIN; IMPLANTATION; IMPACT;
D O I
10.3390/jcm12185978
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Complex atherosclerotic femoro-popliteal lesions have traditionally been treated with bypass surgery. A prosthetic graft is used to save the vein graft for more distal revascularisations or when a vein graft is unavailable. The endovascular approach has gained popularity and is offered as a first-line strategy for complex lesions. This study aimed to evaluate whether endovascular procedures can be used as a first-line treatment strategy for complex native femoro-popliteal lesions over open surgery with prosthetic bypass in patients with peripheral arterial disease (PAD). Methods: This single-centre retrospective observational study was conducted between 2013 and 2021; it included patients with symptomatic PAD who required limb revascularisation at the femoro-popliteal segment and who had complex lesions. The primary endpoints analysed were technical success, primary patency, freedom from clinically driven target lesion revascularisation (cdTLR), freedom from major adverse limb and cardiovascular events (MALE and MACE, respectively), freedom from limb loss, and survival. The secondary endpoints were length of in-hospital stay, and duration and costs of the procedure. Results: We identified 185 limbs among 174 suitable candidates for comparison, wherein 105 were treated with an endovascular procedure and 80 with a femoro-popliteal prosthetic bypass. Most patients in both groups presented with chronic limb-threatening ischaemia, and >90% of them had an American Society of Anesthesiologists (ASA) physical status classification of >3. The endovascular group had more octogenarians (p = 0.02) and patients with coronary disease (p = 0.004). The median follow-up was 30 months. The technical failure rate for endovascular procedures was 4.7%, versus 0% in the open group (p = 0.047). Freedom from MACE was similar in both groups. The endovascular group showed superior primary patency (p < 0.0001), cdTLR (p < 0.0001), MALE (p < 0.0001), and freedom from limb loss (p = 0.0018) at 24 and 48 months. Further analysis performed for the open above-the-knee sub-group showed that the aforementioned endpoints were similar between the groups at 12 months and were better in the endovascular group at 24 and 48 months. Procedural time and in-hospital stay were longer in the open group than in the endovascular group (p < 0.0001 and p < 0.001, respectively). The procedural cost in the endovascular group was 10-fold lower than that in the prosthetic bypass group. Conclusions: Endovascular procedures are safe for treating complex femoro-popliteal lesions in patients at a high risk for surgery and show better outcomes at 24 months than prosthetic bypasses do. The latter may be considered as an alternative should endovascular treatment fail.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The Contemporary Safety and Effectiveness of Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions in the Treatment of Symptomatic Peripheral Arterial Disease
    Tsai, Thomas T.
    Rehring, Thomas F.
    Rogers, R. Kevin
    Shetterly, Susan M.
    Wagner, Nicole M.
    Gupta, Rajan
    Jazaeri, Omid
    Hedayati, Nasim
    Jones, W. Schuyler
    Patel, Manesh R.
    Ho, P. Michael
    Go, Alan S.
    Magid, David J.
    CIRCULATION, 2015, 132 (21) : 1999 - 2011
  • [32] Part One: For the Motion. Lower Extremity Bypass versus Endovascular Therapy for Young Patients with Symptomatic Peripheral Arterial Disease
    Lepantalo, M. J. A.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2012, 44 (02) : 112 - 115
  • [33] Lower extremity bypass vs endovascular therapy for young patients with symptomatic peripheral arterial disease
    Lepantalo, Mauri J. A.
    Houbballah, Rabih
    Raux, Maxime
    LaMuraglia, Glenn
    JOURNAL OF VASCULAR SURGERY, 2012, 56 (02) : 545 - 555
  • [34] 12-Month Primary Patency Rates of Contemporary Endovascular Device Therapy for Femoro-Popliteal Occlusive Disease in 6,024 Patients: Beyond Balloon Angioplasty
    Marmagkiolis, Konstantinos
    Hakeem, Abdul
    Choksi, Nishit
    Al-Hawwas, Malek
    Edupuganti, Mohan Mallikarjuna Rao
    Leesar, Massoud A.
    Cilingiroglu, Mehmet
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 84 (04) : 555 - 564
  • [35] Limb Related Outcomes of Endovascular vs. Open Surgical Revascularisation in Patients with Peripheral Arterial Occlusive Disease: A Report from the Prospective GermanVasc Cohort Study
    Peters, Frederik
    Behrendt, Christian -Alexander
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2023, 66 (01) : 85 - 93
  • [36] Comparison of Outcomes and Cost of Endovascular Management Versus Surgical Bypass for the Management of Lower Extremities Peripheral Arterial Disease
    Doshi, Rajkumar
    Changal, Khalid Hamid
    Gupta, Rajeev
    Shah, Jay
    Patel, Krunalkumar
    Desai, Rupak
    Meraj, Perwaiz
    Syed, Mubbasher Ameer
    Sheikh, A. Mujeeb
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (10): : 1790 - 1796
  • [37] Trans-Atlantic Debate: Lower Extremity Bypass versus Endovascular Therapy for Young Patients with Symptomatic Peripheral Arterial Disease Introduction
    Ricco, J. -B.
    Forbes, T. L.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2012, 44 (02) : 111 - 111
  • [38] Population-Based Outcomes Following Endovascular Interventions and Bypass Surgery for Lower Extremity Peripheral Arterial Disease
    Changal, Khalid Hamid
    Shah, Jay
    Doshi, Rajkumar
    Syed, Mubbasher
    Sheikh, Mujeeb
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B103 - B104
  • [39] THE LONG-TERM QUALITY OF LIFE IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE AFTER PERIPHERAL BYPASS SURGERY
    Van Hattum, Eline S.
    Tangelder, Marco J.
    Lawson, James A.
    Moll, Frans L.
    Algra, Ale
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [40] Anticoagulation or anti-aggregation in bypass surgery for patients with peripheral arterial occlusive disease
    Amendt, K.
    GEFASSCHIRURGIE, 2007, 12 (01): : 63 - 70